Recode Studios Q4 FY26 Share Price & Earnings Call Analysis

₹387.50+0.54% today
Market cap
₹412 Cr
P/E
36.86
ROE
77.92%
PEG
0.24
Price to sales
5.16
Debt to equity
0.31
52W high / low
₹477 / ₹171
EBITDA margin
20.75%
Net profit margin
14.00%
Promoter holding
65.18%
Sales (last year)
₹80 Cr

Incorporated in 2021, Recode Studio is an Indian beauty and personal care company operating under the brand Recode[1]

Guidance scorecard · Q4 FY26 call

What Recode Studios's management guided
and where it ranks in Personal Products

#2of 7 in
Personal Products

RevenueQ4 FY26 call

40%+
  • The company is targeting at least 50% revenue growth in 2027, expecting to achieve this growth momentum in the first half (H1) itself.
  • They project maintaining a 50% CAGR over the next 3 years with consistent margins.
  • Growth drivers include deeper market penetration, channel expansion (both online and offline), and expanded distribution networks.
  • There is a strategic focus on increasing product availability in key markets such as South India, North East India, and Central India.
  • Plans include strengthening presence in modern trade and launching quick commerce delivery services.

2 more points from Recode Studios's call on revenue

Create a free account to keep reading this call

Full Q4 FY26 analysis

MarginsQ4 FY26 call

Flat

See what Recode Studios said on margins — free account, 30 seconds.

Full Q4 FY26 analysis

CapexQ4 FY26 call

Planned
  • The company is investing in its supply chain and distribution network, including a planned large warehouse in Ludhiana expected to commence operations from April 2027.
  • They have shifted from FOFO stores to opening dark stores in multiple cities like Jabalpur, Hyderabad, Chennai, with Bhubaneswar and Ranchi in the pipeline, aiming to optimize costs on rentals, electricity, and labor.
  • Recode is planning to foray into quick commerce within the next 1-2 months and is in discussions with major quick commerce platforms.

2 more points from Recode Studios's call on capex

Create a free account to keep reading this call

Full Q4 FY26 analysis

FundraisingQ4 FY26 call

See what Recode Studios said on fundraising — free account, 30 seconds.

Full Q4 FY26 analysis

Order bookQ4 FY26 call

  • The company is focusing on expanding product availability in key markets such as South India, North East India, and Central India.
  • They opened their first modern trade kiosk recently and have more in the pipeline.
  • Discussions are ongoing with quick commerce platforms to enable deliveries within 4 hours to next day.

2 more points from Recode Studios's call on the order book

Create a free account to keep reading this call

Full Q4 FY26 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Personal Products
on management's own guidance

  1. This stockRecode StudiosStrong growth
    2
  2. Strong growth
    1
  3. 3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Personal Products companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹1,858 Cr55.5
2Recode StudiosThis stock40%+Flat₹408 Cr36.4
3Honasa Consumer Ltd20–40%Up 0–2%₹14,422 Cr57.1
410–20%Flat₹83,720 Cr39.4
510–20%Flat₹64,856 Cr32.7
610–20%Flat₹15,704 Cr20.7

Sign up free to see every company in the sector ranking and track Recode Studios.

Pro shows every company guiding 40%+ revenue growth →Full Personal Products ranking

Financials of Recode Studios

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Recode Studios

Shareholding breakup across reporting periods.

May 2026
Promoters +65.02%
FIIs +3.41%
DIIs +12.26%
Public +19.32%
No. of Shareholders856

Financials of Recode Studios

Quarterly Results

Quarter-by-quarter operating performance

No quarterly results data available for this company yet.

Financials of Recode Studios

Profit & Loss

Annual income statement trend

Mar 2023Mar 2024Mar 2025Mar 2026
Sales +22374880
Expenses +21354263
Operating Profit12617
OPM %7%4.6%13%21%
Other Income +0000
Interest0111
Depreciation0111
Profit before tax10415
Tax %26%26%30%25%
Net Profit +10311
EPS in Rs663.46259.622,990.3813.78
Dividend Payout %0%0%0%0%

Financials of Recode Studios

Balance Sheet

Capital structure and asset base

Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.010.010.018
Reserves55912
Borrowings +4886
Other Liabilities +4379
Total Liabilities13172335
Fixed Assets +1223
CWIP0000
Investments0000
Other Assets +12152132
Total Assets13172335

Financials of Recode Studios

Cash Flows

Operating, investing and financing cash movement

Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-5-234
Cash from Investing Activity +-1-2-1-2
Cash from Financing Activity +63-1-2
Net Cash Flow0-010
Free Cash Flow-6-323
CFO/OP-342%-90%61%73%

Financials of Recode Studios

Ratios

Working capital efficiency and return ratios

Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days54596270
Inventory Days177134171129
Days Payable89307857
Cash Conversion Cycle142163156142
Working Capital Days94596075
ROCE %12%38%74%

What Recode Studios's management said in earlier quarters

Others in Personal Products this season

  • JHS Svendgaard Laboratories (Q2 FY27)

    2,077.1 lakhs in the same quarter of 2025, which reflects an approximate year-on-year growth of 10.8%. Key results statement takeaways from JHS Svendgaard Labor

  • Aakaar Medical (Q2 FY27)

    Revenue from operations in H1 FY27: INR 43.72 Cr, up 72.6% YoY from INR 25.32 Cr in H1 FY26 (Page 12, 11, 4) . Key investor presentation takeaways from Aakaar M

  • Godrej Consumer (Q2 FY27)

    Consolidated net sales for Q2 FY2027: ₹4,396 crore, up 19% year-on-year; constant currency growth 15% (Page 8) . Key investor presentation takeaways from Godrej

  • Colgate-Palmoliv (Q2 FY27)

    1,692 crore, up 12.2% year-on-year from Rs. Key results statement takeaways from Colgate-Palmolive (India) Ltd's Q2 FY27 results statement — and how it ranks ag